Editorial: Kinase inhibitors in cancer therapy

Editorial: Kinase inhibitors in cancer therapy

Bibliographic Details
Main Author:	Dharmendra Kumar Yadav
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	Bax/Bcl-2 kinase inhibitors EGFR pathway RAS-RAF-MEK-ERK pathway RET = rearranged during transfection
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2022.1020297/full

Similar Items

ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01)

Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01)

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
by: Jakob Fleischmann, et al.
Published: (2021-03-01)

Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
by: Yanlin Song, et al.
Published: (2023-01-01)

Three-Pronged Approach to Curb Cancer Metastasis
by: Jariya Kalsoom, et al.
Published: (2023-02-01)

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives
by: Ying Zhang, et al.
Published: (2024-09-01)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01)

Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
by: Jiayi Shen, et al.
Published: (2024-06-01)

Celastrol attenuates amphiregulin expression by inhibiting MAPK signaling pathway in triple-negative breast cancer cells
by: Sangmin Kim, et al.
Published: (2022-08-01)

Molecular inhibition of RAS signalling to target ageing and age-related health
by: Mihails Laskovs, et al.
Published: (2022-10-01)

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy
by: Ozge Tatli, et al.
Published: (2021-12-01)

Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
by: Shaimaa Khattab, et al.
Published: (2025-01-01)

Huanglian Jiedu decoction alleviates neurobehavioral damage in mice with chronic alcohol exposure through the RAS-RAF-MEK-ERK pathway
by: Yun Chen, et al.
Published: (2024-04-01)

Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways
by: Magdalena Holzberg, et al.
Published: (2017-12-01)

Mechanism of Inhibition of Inflammation in Osteoarthritis by Tougu Xiaotong Capsule via Regulating Ras-Raf-MEK1/2-ERK1/2 Signaling Pathway
by: Munan LIN, et al.
Published: (2021-06-01)

Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway
by: Caiguo Huang, et al.
Published: (2013-01-01)

CircRAPGEF5 acts as a modulator of RAS/RAF/MEK/ERK signaling during colorectal carcinogenesis
by: Zhipeng Yin, et al.
Published: (2024-08-01)

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment
by: Tongxuan Guo, et al.
Published: (2023-08-01)

RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors
by: Xi Yuan, et al.
Published: (2020-08-01)

Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity
by: Henna Pehkonen, et al.
Published: (2024-03-01)

Deciphering the pathogenic role of rare RAF1 heterozygous missense mutation in the late-presenting DDH
by: Yuzhao Liu, et al.
Published: (2024-06-01)

TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway
by: Yahui Tian, et al.
Published: (2024-07-01)

RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma
by: Jie Zhou, et al.
Published: (2023-08-01)

ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer
by: Reiko Sugiura, et al.
Published: (2021-09-01)

Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling
by: Zhi-Dong Liu, et al.
Published: (2016-08-01)

Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
by: Yahong Liu, et al.
Published: (2023-09-01)

Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma Cell Lines Resistant to GANT-61
by: Nikolina Piteša, et al.
Published: (2023-05-01)

Unveiling the domain-specific and RAS isoform-specific details of BRAF kinase regulation
by: Tarah Elizabeth Trebino, et al.
Published: (2023-12-01)

Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway
by: Cai W, et al.
Published: (2024-03-01)

Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
by: Rajashri R. Naik, et al.
Published: (2023-01-01)

Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01)

RETRACTED ARTICLE: Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells
by: Shaojun Wang, et al.
Published: (2019-11-01)

The genetic landscape of ganglioglioma
by: Melike Pekmezci, et al.
Published: (2018-06-01)

Remote Continuous Microinjury-Triggered Cytokines Facilitate Severe Diabetic Foot Ulcer Healing via the Ras/Raf/MEK/ERK Pathway
by: Huang X, et al.
Published: (2025-02-01)

A Bioinformatic Analysis Predicts That Cannabidiol Could Function as a Potential Inhibitor of the MAPK Pathway in Colorectal Cancer
by: Julianne du Plessis, et al.
Published: (2024-08-01)

Molecular-genetic mechanisms of the signal cascade RAS-RAF-MEK-ERK associated with the development of the tumor process and the purpose of targeted drugs for colorectal cancer
by: A. N. Toropovsky, et al.
Published: (2021-08-01)

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
by: Penglei Wang, et al.
Published: (2023-12-01)

Influenza A virus replication has a stronger dependency on Raf/MEK/ERK signaling pathway activity than SARS-CoV-2
by: Helen Hoffmann, et al.
Published: (2023-10-01)

Efficiency of B-RAF-/MEK-inhibitors in B-RAF mutated Ameloblastoma: Case report and review of literature
by: Reinhard Büttner, et al.
Published: (2023-12-01)

NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP
by: Yi Wen, et al.
Published: (2022-12-01)